SCHEMBL6488048

SCHEMBL6488048

CC(=O)Nc1c(C)cc(OC(C)=O)cc1NCc1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 2/20 0.39
HDAC1 Q13547 3/20 0.39
APOBEC3A P31941 1/20 0.39
GFER P55789 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
PTPRB P23467 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC2 Q92769 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
DHODH Q02127 1/20 0.37
BACE1 P56817 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492750 0.85 KDM4E (0.43) HPGDKDM4EMAPTGAAHDAC1
SCHEMBL6499126 0.80 DRD2 (0.39) HPGDKDM4EGAAPTPRBHSD17B10
SCHEMBL6303883 0.73 RAB9A (0.59) KDM4EHDAC1APOBEC3AGFERAPOBEC3G
SCHEMBL13351404 0.70 HSD17B10 (0.48) HPGDKDM4EMAPTGAAPTPRB
SCHEMBL6488825 0.70 HPGD (0.36) HPGDPTPRBHSD17B10BACE1
SCHEMBL6600598 0.69 HSD17B10 (0.60) HPGDKDM4EMAPTGAAPTPRB
SCHEMBL6487887 0.69 HPGD (0.35) HPGDPTPRBHSD17B10
SCHEMBL27935472 0.65 BACE1 (0.70) KDM4EMAPTGAAHSD17B10TDP1
SCHEMBL6496310 0.65 THRB (0.41) KDM4EGAAMEN1KMT2A
SCHEMBL14625056 0.64 ALDH1A1 (0.42) HPGDKDM4EMAPTGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD HPGD 2381/4885KDM4E 760/4885MAPT 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.